Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical application.
Desoximetasone (Topisolon; Hoechst), a new topical steroid, and betamethasone 17-valerate were compared with respect to their effects on hypothalamic-pituitary-adrenal function as evidenced by plasma cortisol concentrations. Three grams of each test preparation were applied daily for 21 days to intact skin of the ventral aspects of alternate forearms of 15 normal volunteers. Five received betamethasone 17-valerate 0.1%, 5 desoximetasone 0.05%, and 5 desoximetasone 0.25%. Plasma cortisol levels were determined before and after the initial applications on days 1, 3, 10, 17, 22, 24 and 28. These values were compared with the mean control values by analysis of covariance. There was no significant difference in plasma cortisol levels. The value of performing similar studies on larger skin areas and with larger doses is discussed.
D000287:Administration, Topical; D000328:Adult; D001623:Betamethasone / Q000031:analogs & derivatives*; D001624:Betamethasone Valerate / Q000008:administration & dosage / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D003899:Desoximetasone / Q000008:administration & dosage / Q000494:pharmacology*; D003907:Dexamethasone / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D008297:Male; D012867:Skin / Q000187:drug effects
D003899:Desoximetasone; D003907:Dexamethasone; D001623:Betamethasone; D001624:Betamethasone Valerate; D006854:Hydrocortisone